1. Home
  2. OLMA vs VIRT Comparison

OLMA vs VIRT Comparison

Compare OLMA & VIRT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Olema Pharmaceuticals Inc.

OLMA

Olema Pharmaceuticals Inc.

HOLD

Current Price

$28.17

Market Cap

2.6B

Sector

Health Care

ML Signal

HOLD

Logo Virtu Financial Inc.

VIRT

Virtu Financial Inc.

HOLD

Current Price

$33.32

Market Cap

2.8B

Sector

Finance

ML Signal

HOLD

Company Overview

Basic Information
Metric
OLMA
VIRT
Founded
2006
2008
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Investment Bankers/Brokers/Service
Sector
Health Care
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
2.6B
2.8B
IPO Year
2020
2015

Fundamental Metrics

Financial Performance
Metric
OLMA
VIRT
Price
$28.17
$33.32
Analyst Decision
Strong Buy
Hold
Analyst Count
6
7
Target Price
$40.50
$41.43
AVG Volume (30 Days)
3.4M
906.6K
Earning Date
11-10-2025
01-28-2026
Dividend Yield
N/A
2.84%
EPS Growth
N/A
132.69
EPS
N/A
4.62
Revenue
N/A
$2,694,104,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
$7.33
Revenue Growth
N/A
41.05
52 Week Low
$2.86
$31.89
52 Week High
$36.26
$45.77

Technical Indicators

Market Signals
Indicator
OLMA
VIRT
Relative Strength Index (RSI) 56.71 39.32
Support Level $25.62 $33.30
Resistance Level $36.26 $34.52
Average True Range (ATR) 2.76 0.84
MACD -0.80 -0.17
Stochastic Oscillator 23.97 13.31

Price Performance

Historical Comparison
OLMA
VIRT

About OLMA Olema Pharmaceuticals Inc.

Olema Pharmaceuticals inc is a clinical-stage biopharmaceutical company. It is focused on the discovery, development, and commercialization of next generation targeted therapies for women's cancers. Its therapies offer the potential to improve outcomes for women living with cancer. The company has completed discovery and preclinical studies of OP-1250. OP-3136 is another drug candidate in the company's product pipeline.

About VIRT Virtu Financial Inc.

Virtu Financial Inc is a financial firm that leverages technology to deliver liquidity to the world-wide markets and transparent trading solutions to its clients. The company's operating segment includes Market Making; and Execution Services. The non-operating segment of the company includes the Corporate segment. The company generates maximum revenue from the market-making segment. The Market Making segment principally consists of market-making in the cash, futures, and options markets across equities, options, fixed income, currencies, and commodities. Geographically, it derives a majority of its revenue from the United States and also has a presence in Ireland and Other Countries.

Share on Social Networks: